66 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
culture in RepliCel’s fields of interest.
Additionally, the parties have now executed a new research collaboration agreement intended to optimize … of the world's emerging experts on biomedical engineering and the employment of advanced materials and micro-technologies for cell and tissue culture
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Oct 18
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
9:06am
and Engineering Research Council of Canada has funded a University of Victoria project aimed at collaborating with RepliCel to optimize cell culture … the NSERC Collaborative Research and Development ("CRD") program.
The collaboration will focus on approaches to optimize cell culture platforms
6-K
REPCF
Replicel Life Sciences Inc.
18 May 12
Current report (foreign)
12:00am
. The extent of subject response will be reviewed in relation to subject-factors (age, gender, health status, etc.), cell culture factors (duration … of cell culture, cell morphology, cell protein markers, gene expression, etc.), and environmental factors (duration between biopsy and culture preparation
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
mesenchymal tissue, which elicit more efficient replication potential in culture. Furthermore, the proprietary culture conditions in which RCS-01
6-K
EX-99.1
0jkvf4d9wlt1ui d2g
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
6-K
EX-99.2
bwzqh70cbra4c
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
v644gboux1tgazr
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.2
q1ny85h2fwm 3rdr
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
i7ucz5lxm 660mi3jnmm
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.2
ec710re7fz 10tc3w
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
3d2id rha4kwae9n7r1
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
o86fbvm bm0pe977
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
02eviate4puxskzfi
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.2
7ywjg8zoh4b6tgwbqevb
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
jrd0hc1g
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
wwj5i osrb
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
6-K
EX-99.2
9arsy36i ei4m84r9
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
z5c1w81ysfgd
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
gcrun255j2i
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm